Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy

Fang Xu,Dongpeng Jiang,Jialu Xu,Huaxing Dai,Qin Fan,Ziying Fei,Beilei Wang,Yue Zhang,Qingle Ma,Qianyu Yang,Yitong Chen,Edikan A Ogunnaike,Jianhong Chu,Chao Wang,Edikan A. Ogunnaike

DOI: https://doi.org/10.1016/j.celrep.2023.113138

IF: 8.8

2023-09-22

Cell Reports

Abstract:Xu et al. develop therapeutic dendritic cell-derived bispecific EVs with aCD19 scFv and PD1 expression for targeting tumor antigens and binding immune checkpoint proteins simultaneously. The bispecific EVs accumulate in solid tumor and rebuild the immunosuppressive microenvironment, showing significant primary tumor regression and metastasis inhibition in a mouse model.

cell biology